Study Reports Effectiveness of BBV152 Against COVID-19

The first real-world assessment of BBV152, a COVID-19 vaccine developed in India, suggests that two vaccine doses result in 50% effectiveness against symptomatic COVID-19.

from Medindia Health News https://ift.tt/3HVqnkL